ANNUAL NATA 21st - Programme - Nataonline
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
TI NG
EE
M
A L
U
VI R T
21st April 12-16, 2021
ANNUAL NATA
Son Patient
Y M Blood
P O Management,
SIUM
Haemostasis and Thrombosis
Final
Programme
Are You Improving
Outcomes with SpHb ?
®
Six studies across four continents have found that noninvasive and continuous
haemoglobin (SpHb) monitoring can help improve outcomes1-6
o ve r 7 5 c o u n tr i e s a r o
ort i n g c li n i ci a n s i n und the
is supp world
SpHb .*
33%
30-Day Mortality5
CHU Limoges
2019
87% Patients
Receiving Transfusions1 63% Units €1.7M Cost6
RBC Transfused4 HM Hospitales
Massachusetts 2018
Fukushima Medical
General Hospital 41% RBC Units per University
2014 Transfused Patient2 2016
Cairo University
2015
76% Time to Transfusion3
Cairo University
2016
= Reduction
Improve Your Outcomes with SpHb
Visit www.masimo.co.uk/sphb
For professional use. See instructions Clinical decisions regarding red blood cell transfusions should be based on the clinician’s judgment
for use for full prescribing information, considering among other factors: patient condition, continuous SpHb monitoring, and laboratory
including indications, contraindications, diagnostic tests using blood samples. SpHb monitoring is not intended to replace laboratory blood
warnings, and precautions. testing. Blood samples should be analysed by laboratory instruments prior to clinical decision making.
1
Ehrenfeld et al. J Blood Disorders Transf. 2014. 5:9. 2 Awada WN et al. J Clin Monit Comput. DOI 10.1007/s10877-015-9660-4. Study Protocol: In each group, if researchers noted SpHb trended downward below 10 g/dL,
a red blood cell transfusion was started and continued until SpHb trended upward above 10 g/dL. The transfusion threshold of 10 g/dL was predetermined by the study protocol and may not be appropriate for all patients.
Blood sampling was the same for the control and test group. Arterial blood was drawn from a 20 gauge radial artery cannula into 2 mL EDTA collection tubes, mixed and sent for analysis by a Coulter GEN-S Hematology
Analyzer. 3 Kamal A, et al. Open J of Anesth. 2016 Mar; 6, 13-19. 4 Imaizumi et al. Proceedings from the 16th World Congress of Anaesthesiologists, Hong Kong. Abstract #PR607. 5 Cros et al. J Clin Monit Comput. Aug 2019: PLCO-004676/PLLT-10883E-0221
1-9. Study utilised a goal-directed fluid therapy protocol with PVi® in conjunction with a blood transfusion protocol based on SpHb. 6 Ribed-Sánchez B, et al. Sensors (Basel). 2018 Apr 27;18(5). pii: E1367. Estimated national © 2021 Masimo. All rights reserved.
savings derived from hospital savings extrapolated nationwide. * Data on file.
CONTENTS
Welcome message ..................................................................................................................................................................................... 4
Board of directors ........................................................................................................................................................................................ 5
Scientific committee ........................................................................................................................................................................... 6
Faculty .................................................................................................................................................................................................................................................. 7
CME accreditation ....................................................................................................................................................................................... 9
Scientific programme ...................................................................................................................................................................... 10
E-posters .................................................................................................................................................................................................................................... 20
Industry-sponsored programme .............................................................................................................. 31
Partners, sponsors and exhibitors ........................................................................................................ 39
3
Dear Colleague,
On behalf of the NATA board of directors, it is our pleasure to welcome you to the 21st NATA Symposium
on Patient Blood Management, Haemostasis and Thrombosis that will be held as a 5-day virtual meeting
on April 12-16, 2021.
The Annual NATA Symposium attracts a wide international and multidisciplinary audience from more than
40 countries. In line with our mission statement, the scientific programme covers a wide range of topics
related to anaemia, patient blood management (PBM), critical bleeding and thrombosis.
We are no doubt frustrated not be able to meet face to face in Athens as originally planned. However,
despite these challenging times, the virtual format gives an opportunity to reach a wider, more global
audience. Registration fees have been significantly reduced. We hope this will allow many new participants
to discover our unique multidisciplinary forum.
The preliminary programme includes 11 plenary sessions, of which 9 will be repeated at a different time so
that attendees can participate in live sessions whatever their time zone (note that the online programme
can be displayed according to your time zone). We are also delighted to host sessions organized by the
Society for the Advancement of Patient Blood Management (SABM) and the Asia-Pacific Society for Patient
Blood Management (ASPBM).
This year, 78 abstracts have been accepted for presentation, of which 16 have been selected for oral
communication. They represent an important contribution to the scientific programme. We encourage all
delegates to visit the poster area and to attend the four Best Poster sessions.
A very attractive, busier than ever industry-sponsored programme will complement the main scientific
programme. It includes 6 satellite symposia, 2 workshops and 11 meet-the-expert sessions, many of which
will be repeated.
All sessions will be recorded and will be available on-demand for 6 months on the meeting platform.
More than ever, the annual NATA symposium will provide a unique opportunity for stimulating and
constructive exchanges across different specialities involved in PBM, haemostasis and thrombosis.
We look forward to meeting you virtually at this outstanding event.
Yours sincerely,
Charles-Marc Samama Jens Meier
NATA Chair Chair, NATA Scientific Committe
4
CONGRESS INFORMATION
i
BOARD OF DIRECTORS
CONGRESS INFORMATION
CHAIR
Charles-Marc Samama / Paris, France
MEMBERS
Elvira Bisbe / Barcelona, Spain Jens Meier / Linz, Austria
David Faraoni / Toronto, ON, Canada Manuel Muñoz / Málaga, Spain
Beverley J. Hunt / London, UK Toby Richards / Perth, WA, Australia
Jean-François Hardy / Montreal, QC, Canada Maria Beatrice Rondinelli / Rome, Italy
Sigismond Lasocki / Angers, France
5
CONGRESS INFORMATION
i
SCIENTIFIC COMMITTEE
CONGRESS INFORMATION
CHAIR
Jens Meier / Linz, Austria
MEMBERS
Michael Auerbach / Baltimore, MD, USA Marcel Levi / London, UK
Elvira Bisbe / Barcelona, Spain Jerrold H. Levy / Durham, NC, USA
Jeffrey L. Carson / New Brunswick, NJ, USA Manuel Muñoz / Málaga, Spain
David Faraoni / Toronto, ON, Canada Helen V. New / London, UK
Thomas Frietsch / Mannheim, Germany Marco Pavesi / Milan, Italy
Bernd Froessler / Adelaide, SA, Australia Hanne Berg Ravn / Copenhagen, Denmark
José Antonio García-Erce / Pamplona, Spain Toby Richards / Perth, WA, Australia
Lawrence Tim Goodnough / Stanford, CA, USA Maria Beatrice Rondinelli / Rome, Italy
Oliver Grottke / Aachen, Germany Charles-Marc Samama / Paris, France
Thorsten Haas / Zurich, Switzerland Ignacio Sarmiento Goldberg / Providencia, Chile
Jean-François Hardy / Montreal, QC, Canada Jakob Stensballe / Copenhagen, Denmark
Beverley J. Hunt / London, UK Alexander Vlaar / Amsterdam, The Netherlands
Giovanni Inghilleri / Milan, Italy Christian von Heymann / Berlin, Germany
Sigismond Lasocki / Angers, France Jonathan H. Waters / Pittsburgh, PA, USA
6
CONGRESS INFORMATION
i
FACULTY
CONGRESS INFORMATION
Ane Abad Motos / Madrid, Spain Susan M. Goobie / Boston, MA, USA
Sandaruwani Abeysiri / London, UK Klaus Görlinger / Munich, Germany
Sílvia Amaral / Coimbra, Portugal Laura Green / London, UK
Fredy Ariza Cadena / Cali, Colombia Oliver Grottke / Aachen, Germany
Michael Auerbach / Baltimore, MD, USA Elisavet Grouzi / Athens, Greece
David Baron / Vienna, Austria Nicole R. Guinn / Durham, NC, USA
Eva Bassas Parga / Barcelona, Spain Ludhmila Abrahão Hajjar / São Paulo, SP, Brazil
Hanne Berg Ravn / Copenhagen, Denmark Thorsten Haas / Zurich, Switzerland
Elvira Bisbe / Barcelona, Spain Jean-François Hardy / Montreal, QC, Canada
Carolyn Burns / Louisville, KY, USA Sarah Haynes / Manchester, UK
Katerina Cabolis / London, UK Stefan Hofer / Kaiserslautern, Germany
Jeannie Callum / Toronto, ON, Canada Axel Hofmann / Zurich, Switzerland
Jeffrey L. Carson / New Brunswick, NJ, USA Wim Houdijk / St-Niklaas, Belgium
Sebastian Casu / Salzgitter, Germany Beverley J. Hunt / London, UK
Dongho Choi / Seoul, South Korea Giovanni Inghilleri / Milan, Italy
Howard L. Corwin / Danville, PA, USA Hongwen Ji / Beijing, China
Luis Teodoro da Luz / Toronto, ON, Canada Keyvan Karkouti / Toronto, ON, Canada
Marta De la Rosa-Estadella / Barcelona, Spain Shunji Kawamoto / Kanagawa, Japan
Cory Dugan / Perth, WA, Australia Jaewhoan Koh / Gyeonggi, South Korea
Caroline Evans / Cardiff, Wales, UK Ananthi Krishnamoorthy / Ipoh, Perak, Malaysia
David Faraoni / Toronto, ON, Canada Sigismond Lasocki / Angers, France
Daniela Filipescu / Bucharest, Romania Cheuk-Kwong Lee / Hong Kong, China
Dania Fischer / Frankfurt, Germany Jeong-jae Lee / Seoul, South Korea
Patricia Forest Villegas / Lyon, France Jonghyeon Lee / Seoul, South Korea
Tine François / Montreal, QC, Canada Marcel Levi / London, UK
Thomas Frietsch / Mannheim, Germany Jerrold H. Levy / Durham, NC, USA
Bernd Froessler / Adelaide, SA, Australia Jürgen Thomas Lutz / Cologne, Germany
Angelina Gapay / Tacloban City, Leyte, Philippines Marc Maegele / Cologne, Germany
José Antonio García-Erce / Pamplona, Spain Alexandre Mansour / Rennes, France
Marlene C. Gerner / Vienna, Austria Yuyun Maryuningsih / Geneva, Switzerland
Ismail Gögenur / Køge, Denmark Jens Meier / Linz, Austria
7CONGRESS INFORMATION
i
FACULTY
CONGRESS INFORMATION
Patrick Meybohm / Würzburg, Germany Ignacio Sarmiento Goldberg / Providencia, Chile
Anders Møller / Slagelse, Denmark Jameela Sathar / Selangor, Malaysia
Lidia Mora Miquel / Barcelona, Spain Christoph Schlimp / Linz, Austria
Manuel Muñoz / Málaga, Spain Herbert Schöchl / Salzburg, Austria
Helen V. New / London, UK Timo Seyfried / Regensburg, Germany
Joshua Nicholas / Calgary, AB, Canada Aryeh Shander / Englewood, NJ, USA
Arno Nierich / Zwolle, The Netherlands Paolo Simioni / Padua, Italy
Eric Noll / Strasbourg, France Donat R. Spahn / Zurich, Switzerland
Charlotte Oliver / Cardiff, Wales, UK Bruce D. Spiess / Gainesville, FL, USA
Dion Osemwengie / Zwolle, The Netherlands Philip C. Spinella / St. Louis, MO, USA
Alexandre Ouattara / Bordeaux, France Philippe Gabriel Steg / Paris, France
Sherri Ozawa / Englewood, NJ, USA Jakob Stensballe / Copenhagen, Denmark
Jong-Hoon Park / Seoul, Korea Pierre Tibi / Prescott, AZ, USA
Kiew Kong Pau / Kuala Lumpur, Malaysia Tina Tomi ć Mahe i / Zagreb, Croatia
Isabell Pekrul / Munich, Germany Kevin Trentino / Perth, WA, Australia
Augusto Pérez-Calatayud / Mexico City, Mexico Johanna van der Bom / Leiden, The Netherlands
Valentina Pigozzo / Milan, Italy Alexander P. J. Vlaar / Amsterdam, The Netherlands
Julien Pottecher / Strasbourg, France Christian von Heymann / Berlin, Germany
Toby Richards / Perth, WA, Australia Jonathan H. Waters / Pittsburgh, PA, USA
Michelle Roets / Brisbane, QLD, Australia Linda K. Wijaya / Perth, WA, Australia
Maria Beatrice Rondinelli / Rome, Italy Byung-Hoon Yoo / Seoul, South Korea
David Royston / Harefield, UK Young Jin Yuh / Seoul, South Korea
Charles-Marc Samama / Paris, France Kai Zacharowski / Frankfurt, Germany
8CME ACCREDITATION
CME ACCREDITATION
The 21st Annual NATA Symposium is accredited by the European
Accreditation Council for Continuing Medical Education (EACCME) to
provide the following CME activity for medical specialists. The EACCME
is an institution of the European Union of Medical Specialists (UEMS),
www.uems.net.
The 21st Annual NATA Symposium has been accredited by the European
Accreditation Council for Continuing Medical Education (EACCME®) for a
maximum of 20 European CME credits (ECMEC®s).
Each medical specialist should claim only those hours of credit that he/
she actually spent in the educational activity.
Through an agreement between the European Union of Medical
Specialists and the American Medical Association, physicians
may convert EACCME credits to an equivalent number of
AMA PRA Category 1 Credits™. Information on the process
to convert EACCME credit to AMA credit can be found at www.ama-assn.
org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by
the UEMS-EACCME for ECMEC credits are deemed to be Accredited
Group Learning Activities (Section 1) as defined by the Maintenance of
Certification Program of The Royal College of Physicians and Surgeons of
Canada.
EACCME credits
Each medical specialist should claim only those hours of credit that he/
she actually spent in the educational activity. The EACCME credit system
is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day
and 6 ECMECs for a full-day event.
9SCIENTIFIC PROGRAMME
Monday, April 12, 2021
Plenary session 1A
SAFETY OF BLOOD AND BLOOD PRODUCTS
Chairs: Charles-Marc Samama, Paris, France
Maria Beatrice Rondinelli, Rome, Italy
Cheuk-Kwong Lee, Hong Kong, China
Transfusion-related immunomodulation – theoretical or clinically relevant?
9:00-9:15 CEST David Baron, Vienna, Austria
Pathogen testing in 2021 – what is necessary?
9:15-9:30 CEST Maria Beatrice Rondinelli, Rome, Italy
Age of blood – problem solved or ongoing debate?
9:30-9:45 CEST Philip C. Spinella, St. Louis, MO, USA
9:45-10:00 CEST Discussion
Plenary session 2A
HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE
Chairs: Jens Meier, Linz, Austria
Young Jin Yuh, Seoul, South Korea
Alexander Vlaar, Amsterdam, The Netherlands
How to approach liberal vs. restrictive transfusion
11:30-11:45 CEST Anders Møller, Slagelse, Denmark
Transfusion strategy in myocardial infarction – REALITY trial
11:45-12:00 CEST Philippe Gabriel Steg, Paris, France
Whole blood – now or never?
12:00-12:15 CEST Jakob Stensballe, Copenhagen, Denmark
12:15-12:30 CEST Discussion
Best Poster session
BEST POSTERS — ORAL COMMUNICATIONS (PART 1)
Chairs: Jens Meier, Linz, Austria
Jean-François Hardy, Montreal, QC, Canada
Erythrocytes inhibit T-cell activation by modulation of redox state
13:15-13:20 CEST Marlene C. Gerner, Vienna, Austria
Intraoperative cell salvage as an alternative to allogeneic blood transfusion: an evaluation of the
13:20-13:25 CEST immune response profile
Michelle Roets, Brisbane, QLD, Australia
Combined intraoperative platelet and erythrocyte salvage: first evaluation of a new autotransfusion
13:25-13:30 CEST device
Alexandre Mansour, Rennes, France
Cell salvage: A decade of haemovigilance reporting in the UK
13:30-13:35 CEST Sarah Haynes, Manchester, UK
13:35-13:45 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 10
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Monday, April 12, 2021
Best Poster session
BEST POSTERS — ORAL COMMUNICATIONS (PART 2)
Chairs: Elvira Bisbe, Barcelona, Spain
Ignacio Sarmiento Goldberg, Providencia, Chile
Blood donation and transfusion during the first wave of COVID-19 pandemic in Spain: different impact
15:45-15:50 CEST according to autonomous communities and hospitals
José Antonio García-Erce, Pamplona, Spain
McCluskey risk index application to blood transfusion needs in liver transplantation at Coimbra
15:50-15:55 CEST Hospital and University Center — Is blood transfusion no more unpredictable?
Sílvia Amaral, Coimbra, Portugal
Should we continue routine preoperative blood ordering in orthopaedic surgery?
15:55-16:00 CEST Eva Bassas Parga, Barcelona, Spain
A descriptive Blood sample Volume Analysis in a Multidisciplinary Pediatric Intensive caRE unit
16:00-16:05 CEST (B-VAMPIRE)
Tine François, Montreal, QC, Canada
16:05-16:15 CEST Discussion
Plenary session 3A
PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE
Chairs: Elvira Bisbe, Barcelona, Spain
Nicole R. Guinn, Durham, NC, USA
Hanne Berg Ravn, Copenhagen, Denmark
The basics of PBM – pillar 1
17:00-17:15 CEST Ane Abad Motos, Madrid, Spain
The basics of PBM – pillar 2
17:15-17:30 CEST Dania Fischer, Frankfurt, Germany
The basics of PBM – pillar 3
17:30-17:45 CEST Tina Tomić Mahečić, Zagreb, Croatia
17:45-18:00 CEST Discussion
Plenary session 4A
HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION
Chairs: Sigismond Lasocki, Angers, France
Christian von Heymann, Berlin, Germany
José A. García-Erce, Pamplona, Spain
Top 5 most important PBM publications in 2020–2021
19:30-19:45 CEST David Faraoni, Toronto, ON, Canada
RCTs in PBM – do they give us all the answers?
19:45-20:00 CEST Kevin Trentino, Perth, WA, Australia
Maturity Assessment in PBM – monitoring implementation at the national level
20:00-20:15 CEST Elvira Bisbe, Barcelona, Spain
20:15-20:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 11
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Tuesday, April 13, 2021
Plenary session 3B
PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE
Chairs: Sigismond Lasocki, Angers, France
Jameela Sathar, Selangor, Malaysia
Giovanni Inghilleri, Milan, Italy
The basics of PBM – pillar 1
9:00-9:15 CEST Ane Abad Motos, Madrid, Spain
The basics of PBM – pillar 2
9:15-9:30 CEST Dania Fischer, Frankfurt, Germany
The basics of PBM – pillar 3
9:30-9:45 CEST Tina Tomić Mahečić, Zagreb, Croatia
9:45-10:00 CEST Discussion
Plenary session 4B
HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION
Chairs: Manuel Muñoz, Málaga, Spain
Daniela Filipescu, Bucharest, Romania
Jeong-jae Lee, Seoul, South Korea
Top 5 most important PBM publications in 2020–2021
11:30-11:45 CEST David Faraoni, Toronto, ON, Canada
RCTs in PBM – do they give us all the answers?
11:45-12:00 CEST Kevin Trentino, Perth, WA, Australia
Maturity Assessment in PBM – monitoring implementation at the national level
12:00-12:15 CEST Elvira Bisbe, Barcelona, Spain
12:15-12:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 12
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Tuesday, April 13, 2021
Plenary session 1B
SAFETY OF BLOOD AND BLOOD PRODUCTS
Chairs: Beverley J. Hunt, London, UK
Jeannie Callum, Toronto, ON, Canada
Jerrold H. Levy, Durham, NC, USA
Transfusion-related immunomodulation – theoretical or clinically relevant?
17:00-17:15 CEST David Baron, Vienna, Austria
Pathogen testing in 2021 – what is necessary?
17:15-17:30 CEST Maria Beatrice Rondinelli, Rome, Italy
Age of blood – problem solved or ongoing debate?
17:30-17:45 CEST Philip C. Spinella, St. Louis, MO, USA
17:45-18:00 CEST Discussion
Plenary session 2B
HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE
Chairs: Jean-François Hardy, Montreal, QC, Canada
Jeffrey L. Carson, New Brunswick, NJ, USA
Ludhmila Abrahão Hajjar, São Paulo, SP, Brazil
How to approach liberal vs. restrictive transfusion
19:30-19:45 CEST Anders Møller, Slagelse, Denmark
Transfusion strategy in myocardial infarction – REALITY trial
19:45-20:00 CEST Philippe Gabriel Steg, Paris, France
Whole blood – now or never?
20:00 -20:15 CEST Jakob Stensballe, Copenhagen, Denmark
20:15-20:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 13
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Wednesday, April 14, 2021
Plenary session 5A
CELL SALVAGE – OUTDATED OR UP TO DATE?
Chairs: Toby Richards, Perth, WA, Australia
Jonghyeon Lee, Seoul, South Korea
Thomas Frietsch, Mannheim, Germany
Cell salvage in paediatrics
9:00-9:15 CEST Susan M. Goobie, Boston, MA, USA
Cell salvage in the bleeding trauma patient
9:15-9:30 CEST Lidia Mora Miquel, Barcelona, Spain
Cell salvage in cancer surgery – a no go?
9:30-9:45 CEST Timo Seyfried, Regensburg, Germany
9:45-10:00 CEST Discussion
Plenary session 6A
HOT TOPICS III – PERIOPERATIVE ANAEMIA AND IRON DEFICIENCY
Chairs: Maria Beatrice Rondinelli, Rome, Italy
Dongho Choi, Seoul, South Korea
Bernd Froessler, Adelaide, SA, Australia
The anaemia clinic – a must for every hospital
11:30-11:45 CEST Elvira Bisbe, Barcelona, Spain
Preoperative IV iron in major abdominal surgery: PREVENTT trial
11:45-12:00 CEST Toby Richards, Perth, WA, Australia
EPO – a new kid on the block?
12:00-12:15 CEST Sigismond Lasocki, Angers, France
12:15-12:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 14
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Wednesday, April 14, 2021
Plenary session 7A
PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?
Chairs: Jens Meier, Linz, Austria
Aryeh Shander, Englewood, NJ, USA
Marcel Levi, London, UK
WHO Action framework for blood products – focus on PBM
17:00-17:15 CEST Yuyun Maryuningsih, Geneva, Switzerland
Levels of PBM implementation – a global view
17:15-17:30 CEST Axel Hofmann, Zurich, Switzerland
Stakeholders’ perspectives on PBM
17:30-17:45 CEST Jens Meier, Linz, Austria
17:45-18:00 CEST Discussion
Plenary session 8
SABM SESSION – A PRACTICAL APPROACH TO PATIENT BLOOD MANAGEMENT
Chairs: Carolyn Burns, Louisville, KY, USA
Charles-Marc Samama, Paris, France
Jean-François Hardy, Montreal, QC, Canada
The role of the surgeon in PBM
19:30-19:45 CEST Pierre Tibi, Prescott, AZ, USA
The role of a PBM coordinator
19:45-20:00 CEST Sherri Ozawa, Englewood, NJ, USA
Wind of change – how to initiate PBM in real life?
20:00 -20:15 CEST Aryeh Shander, Englewood, NJ, USA
20:15-20:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 15
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Thursday, April 15, 2021
Plenary session 7B
PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?
Chairs: Elvira Bisbe, Barcelona, Spain
Ananthi Krishnamoorthy, Ipoh, Perak, Malaysia
Kai Zacharowski, Frankfurt, Germany
WHO Action framework for blood products – focus on PBM
9:00-9:15 CEST Yuyun Maryuningsih, Geneva, Switzerland
Levels of PBM implementation – a global view
9:15-9:30 CEST Axel Hofmann, Zurich, Switzerland
Stakeholders’ perspectives on PBM
9:30-9:45 CEST Jens Meier, Linz, Austria
9:45-10:00 CEST Discussion
Plenary session 9
ASPBM SESSION – INSIGHT INTO PATIENT BLOOD MANAGEMENT IN ASIA
Chairs: Jeong-jae Lee, Seoul, South Korea
Jaewhoan Koh, Gyeonggi, South Korea
Jens Meier, Linz, Austria
PBM in South Korea and the birth of ASPBM
11:30-11:45 CEST Jong-Hoon Park, Seoul, Korea
PBM in China: a nationwide endeavour
11:45-12:00 CEST Hongwen Ji, Beijing, China
PBM – the Challenge of unmet needs in Asia
12:00-12:15 CEST Angelina Gapay, Tacloban City, Leyte, Philippines
12:15-12:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 16
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Thursday, April 15, 2021
Plenary session 10A
PATIENT BLOOD MANAGEMENT IN THE ICU
Chairs: David Faraoni, Toronto, ON, Canada
Augusto Pérez-Calatayud, Mexico City, Mexico
Howard L. Corwin, Danville, PA, USA
Role of iron and EPO in the ICU
17:00-17:15 CEST Sigismond Lasocki, Angers, France
Coagulopathies in the ICU
17:15-17:30 CEST Isabell Pekrul, Munich, Germany
Transfusion triggers for critically ill patients – ESICM guidelines
17:30-17:45 CEST Alexander P. J. Vlaar, Amsterdam, The Netherlands
17:45-18:00 CEST Discussion
Plenary session 11A
HOT TOPICS IV – BLEEDING AND THROMBOSIS
Chairs: Charles-Marc Samama, Paris, France
Ignacio Sarmiento Goldberg, Providencia, Chile
Fredy Ariza Cadena, Cali, Colombia
When to use tranexamic acid?
19:30-19:45 CEST Beverley J. Hunt, London, UK
Point-of-care coagulation monitoring – the way to go
19:45-20:00 CEST Jakob Stensballe, Copenhagen, Denmark
COVID-19, haemostasis and thrombosis
20:00 -20:15 CEST Beverley J. Hunt, London, UK
20:15-20:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 17
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Friday, April 16, 2021
Plenary session 10B
PATIENT BLOOD MANAGEMENT IN THE ICU
Chairs: Jens Meier, Linz, Austria
Kiew Kong Pau, Kuala Lumpur, Malaysia
Shunji Kawamoto, Kanagawa, Japan
Role of iron and EPO in the ICU
9:00-9:15 CEST Sigismond Lasocki, Angers, France
Coagulopathies in the ICU
9:15-9:30 CEST Isabell Pekrul, Munich, Germany
Transfusion triggers for critically ill patients – ESICM guidelines
9:30-9:45 CEST Alexander P. J. Vlaar, Amsterdam, The Netherlands
9:45-10:00 CEST Discussion
Plenary session 11B
HOT TOPICS IV – BLEEDING AND THROMBOSIS
Chairs: Charles-Marc Samama, Paris, France
Elisavet Grouzi, Athens, Greece
Byung-Hoon Yoo, Seoul, South Korea
When to use tranexamic acid?
11:30-11:45 CEST Beverley J. Hunt, London, UK
Point-of-care coagulation monitoring – the way to go
11:45-12:00 CEST Jakob Stensballe, Copenhagen, Denmark
COVID-19, haemostasis and thrombosis
12:00-12:15 CEST Beverley J. Hunt, London, UK
12:15-12:30 CEST Discussion
Best Poster session
BEST POSTERS — ORAL COMMUNICATIONS (PART 3)
Chairs: Sigismond Lasocki, Angers, France
Bernd Froessler, Adelaide, SA, Australia
Iron deficiency reduces mitochondrial respiration and changes mitochondrial morphology
12:35-12:40 CEST in mouse skeletal muscle tissue
Katerina Cabolis, London, UK
A retrospective cohort review of pre-operative anaemia and postoperative outcomes
12:40-12:45 CEST in 1,751 colorectal surgical patients
Charlotte Oliver, Cardiff, Wales, UK
Comparison of two intravenous iron regimens in the treatment of postoperative anaemia after
12:45-12:50 CEST colorectal cancer surgery
Marta De la Rosa-Estadella, Barcelona, Spain
Evaluation of serum phosphate levels in surgical patients receiving intravenous ferric carboxymaltose
12:50-12:55 CEST Linda K. Wijaya, Perth, WA, Australia
12:55-13:05 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 18
CEST, Central European Summer Time (UTC +2)SCIENTIFIC PROGRAMME
Friday, April 16, 2021
Best Poster session
BEST POSTERS — ORAL COMMUNICATIONS (PART 4)
Chairs: Maria Beatrice Rondinelli, Rome, Italy
Jakob Stensballe, Copenhagen, Denmark
The need to screen for anaemia in fit and healthy women
15:45-15:50 CEST Cory Dugan, Perth, WA, Australia
Charting the course of ‘Gynaemia’ (Patients with Anaemia undergoing Gynaecological Onco-surgery)
15:50-15:55 CEST Sandaruwani Abeysiri, London, UK
Early plasma transfusion and maternal outcomes in women with postpartum haemorrhage: Does the
15:55-16:00 CEST amount of resuscitation fluids matter?
Johanna van der Bom, Leiden, The Netherlands
Procoagulant membrane dynamics: a novel approach to identify platelet activation in pre-eclampsia
16:00-16:05 CEST Joshua Nicholas, Calgary, AB, Canada
16:05-16:15 CEST Discussion
Plenary session 5B
CELL SALVAGE – OUTDATED OR UP TO DATE?
Chairs: David Faraoni, Toronto, ON, Canada
Jonathan H. Waters, Pittsburgh, PA, USA
Thorsten Haas, Zurich, Switzerland
Cell salvage in paediatrics
17:00-17:15 CEST Susan M. Goobie, Boston, MA, USA
Cell salvage in the bleeding trauma patient
17:15-17:30 CEST Lidia Mora Miquel, Barcelona, Spain
Cell salvage in cancer surgery – a no go?
17:30-17:45 CEST Timo Seyfried, Regensburg, Germany
17:45-18:00 CEST Discussion
Plenary session 6B
HOT TOPICS III – PERIOPERATIVE ANAEMIA AND IRON DEFICIENCY
Chairs: Manuel Muñoz, Málaga, Spain
Michael Auerbach, Baltimore, MD, USA
The anaemia clinic – a must for every hospital
19:30-19:45 CEST Elvira Bisbe, Barcelona, Spain
Preoperative IV iron in major abdominal surgery: PREVENTT trial
19:45-20:00 CEST Toby Richards, Perth, WA, Australia
EPO – a new kid on the block?
20:00 -20:15 CEST Sigismond Lasocki, Angers, France
20:15-20:30 CEST Discussion
Plenary session (morning CEST) Plenary session (afternoon CEST) Best Poster session 19
CEST, Central European Summer Time (UTC +2)E-POSTERS
Blood Transfusion Services / Risks of Transfusion
P1
Blood donation and transfusion during the first wave of COVID pandemic in Spain: different impact according to
autonomous communities and hospitals
J. García Erce, Í. Romón Alonso, C. Jericó Alba, S. Zalba Marcos, J. L. Bueno Cabrera, J. M. Domingo Morera, J. L. Arroyo, C. Sola Lapeña,
E. Chica Gullón, V. Recasens Flores, M. J. Laso Morales, A. Abad Motos, M. L. Antelo Caamaño, A. Galbete Jiménez & M. Quintana Díaz
Banco de Sangre y Tejidos de Navarra, Servicio Navarro Salud, Grupo Español de Rehabilitación Multimodal (GERM), IACS, Zaragoza,
Grupo IdiPaz Madrid, Pamplona; Servicio Hematología y Hemoterapia, Universitario Marqués de Valdecilla, Santander; Hospital Sant
Joan Despí de Barcelona Servicio de Medicina Interna, Barcelona; 4Servicio Hematología-Hemoterapia, Complejo Hospitalario
de Navarra, Pamplona; Servicio Hematología-Hemoterapia, Hospital Universitario Puerta de Hierro, Majadahonda-Madrid; Banco
de Sangre y Tejidos de Aragón, Zaragoza; Banco de Sangre y Tejidos de Cantabria, Santander; Centro y Servicio de Transfusión de
la Rioja, Logroño, Spain; Servicio Anestesia y Reanimación, Hospital Infanta Leonor, Madrid; Servicio de Medicina Intensiva, Hospital
Universitario La Paz, Grupo IdiPaz Madrid, Spain
P2
Relationship between ABO blood group distribution and COVID-19 infection in hospitalized patients: a multicenter
observational Spanish study
C. Jericó2, S. Zalba-Marcos3, A. Abad-Motos4, M. J. Laso-Morales5, M. Subirà6, E. Sancho7, O. López-Villar8, E. Bassas2, M. L. Antelo3,
M. Quintana-Diaz9 & J. A. García-Erce1
1
Blood and Tissue Bank of Navarra, Pamplona; 2Hospital Sant Joan Despí, Barcelona; 3Complejo Hospitalario de Navarra, Pamplona;
4
Hospital U. Infanta Leonor, Madrid; 5Hospital U. Parc Tauli, Barcelona; 6Hospital Sagrat Cor, Barcelona; 7Hospital de Granollers;
Barcelona; 8Hospital U. de Salamanca, Salamanca; 9Hospital U. La Paz, Madrid, Spain
P3
Can plasmapheresis procedure be optimised? The role of plasma unit weight
C. Marraccini1, E. Quartieri3, S. Pulcini1, G. Molinari1, L. Merolle1, P. G. Rossi2, R. Baricchi1 & T. A. Pertinhez1,3
1
Transfusion Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; 2Epidemiology Unit, Azienda USL-IRCCS di
Reggio Emilia, Reggio Emilia, Italy; 3Department of Medicine and Surgery, University of Parma, Parma, Italy
P4
Erythrocytes inhibit T-cell activation by modulation of redox state
M. C. Gerner1,2, A. Bileck3, L. Janker3, T. Öhlinger4, C. Gerner3, K. G. Schmetterer1 & D. M. Baron4
1
Department of Laboratory Medicine, Medical University of Vienna; 2FH Campus Wien, University of Applied Sciences, Section
Biomedical Science, Vienna; 3Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna; 4Department of
Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Vienna, Austria
20E-POSTERS Transfusion Practice P5 Evolution of blood donation and component consume in Navarra (North Spain) (2012-2017): Possible influence of a preliminary patient blood management program J. A. García-Erce1,3,4, S. Zalba Marcos2, A. Aranguren Azparren2, M. L. Antelo Caamaño2, J. R. Ortiz Gómez2 & G. Cerdán5 1 Banco de Sangre y Tejidos de Navarra; 2Complejo Hospitalario de Navarra; 3IdiPAZ49 “Investigación en PBM”; 4AWGE-GIEMSA, Spain P6 High frequency of anti-D antibodies in men – What to do? S. I. Donskov1, L. A. Gusachenko2, A. V. Zinovieva3, B. M. Urtaev1 & R. A. Simanin1 1 Evdokimov Moscow State Medical Dental University, Moscow, Russia; 2Blood Transfusion Station, Surgut, Russia; 3District Clinical Hospital, Khanty-Mansiysk, Russia P7 Analytical parameters and other predictive transfusion risk variables in patients candidate for programmed arthroplasty S. Zalba Marcos1, E. Martin Rodríguez2, L. Muñoa Oteiza2, M. Polo Gil2, I. Plaja Martí2, J. R. Varela Egocheaga2, A. Aranguren Azparren1, A. Galbete Jiménez1, G. Cerdán Rodríguez2 & J. A. García Erce3 1 Complejo Hospitalario de Navarra; 2Hospital García Orcoyen; 3Banco de Sangre y Tejidos de Navarra, Spain P8 Should we continue routine preoperative blood ordering in orthopedic surgery? E. Bassas1, C. Jericó2, A. Tejedor1, C. Deiros1, J. Vericat3 & J. Masdeu1 1 Anesthesiology; 2PBM group; 3Computer Systems, Hospital Sant Joan Despí Moisès Broggi, Consorci Sanitari Integral, Barcelona, Spain P9 McCluskey risk index application to blood transfusion needs in liver transplantation at Coimbra Hospital and University Center - Blood transfusion is no more unpredictable? C. Guedes, S. Amaral & J. Tomaz Coimbra Hospital and University Center, Coimbra, Portugal P10 Postpartum haemorrhage: is there space for blood saving? L. Vieira, R. Pombal, S. Lopes, R. Neto, H. Cruz Gomes, A. Magalhães & M. Figueiredo Immunohemotherapy Service, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal P11 Administration of blood products in obstetrics 2019-2020 at Royal Cornwall Hospital, Truro, UK K. Sprigge Royal Cornwall Hospital, Cornwall, UK P12 Blood transfusion in patients undergoing venovenous extracorporeal membrane oxygenation – a call for patient blood management standardized strategies S. Lopes1, M. A. Canelas2, R. Pombal1, L. Vieira1, R. Neto1, H. Cruz Gomes1, P. Fernandes2 & P. Castelões2 1 Serviço de Imunohemoterapia, Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E., Portugal; 2Serviço de Medicina Intensiva, Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E., Portugal 21
E-POSTERS
P13
Massive transfusion protocol in traumatic patient: to be or not to be?
C. Sáez, J. Martínez, M. De la Rosa M & M. Barquero
P14
Assessment of massive transfusion protocol level of compliance in 5 high level university hospitals
P. Paniagua1, G. Urrutia1, M. Rincón2, A. Candela3, M. Barquero4, M. Marcos5, R. Diaz1, M. Felipe1, A. Batalla1, L. Cueva1, R. Anaya1, M. Giné1,
A. Arellano1 & D. Garrido1
1
Hospital Sta Creu i Sant Pau, Barcelona; 2Virgen del Rocio, Sevilla; 3Ramón y Cajal, Madrid; 4Parc Taulí, Sabadell; 5Clínica
Universitaria, Navarra, Spain
P15
The impact of massive transfusion predictive scores: a retrospective cohort study
M. De la Rosa-Estadella, C. Sáez, J. Martínez & M. Barquero
Department of Anaesthesiology, Parc Tauli University Hospital, Barcelona, Spain
P16
Are Norwegian hospitals following the single-unit policy recommendations?
A. Espinosa1, A. Aandahl2, J. Kronborg3 & M. Arsenovic4
1
Oslo University Hospital, Oslo, Norway; 2Akershus University Hospital, Lørenskog, Norway; 3Innlandet Hospital, Lillehammer, Norway;
4
University Hospital North Norway, Norway
P17
Trends in single-unit red blood cell ordering practice at a medium sized Norwegian university hospital in the period
2016-2019
A. Aandahl
Akershus University Hospital, Norway
P18
Was a large randomized controlled trial comparing red cell transfusion strategies associated with a change in practice?
K. Trentino, F. Sanfilippo, M. Leahy, S. Farmer, I. Gilfillan & K. Murray
The University of Western Australia, Royal Perth Hospital, and Fiona Stanley Hospital, Perth, Australia
P19
The impact of PBM introduction on transfusion practices in colorectal cancer surgical patients
T. Tomić Mahečić1, I. Tucić1, D. Karmelić1, K. Lojna1, M. Moguš1, A. Jumić1, B. Habijanec2 & S. Mihaljević1,3
1
Department for Anaesthesiology and ICU, University Hospital Centre Zagreb, Zagreb; 2Data Raven j.d.o.o., Zagreb; 3University of
Zagreb School of Medicine, Zagreb, Croatia
P20
The effect of patient blood management system on the optimal transfusion: an experience of Asia’s first minimal blood
transfusion-based hospital
H. K. Ahn1, H. J. Shin2, J. S. Jung3 & J. H. Park4
1
Department of Obstetrics and Gynecology, Korea University College of Medicine, Anam Hospital, Seoul, Republic of Korea;
2
Department of Anesthesiology and Pain Medicine, Korea University College of Medicine, Anam Hospital, Seoul, Republic of Korea;
3
Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine, Anam Hospital, Seoul, Republic of Korea;
4
Department of Orthopedic Surgery, Korea University College of Medicine, Anam Hospital, Seoul, Republic of Korea
22E-POSTERS
Blood Conservation Strategies / Autologous Transfusion
P21
Intraoperative cell salvage for shoulder replacements
O. Pietroni
Royal Cornwall Hospitals NHS Trust, Truro, UK
P22
Single-centre, two-year experience with blood salvaging in total hip or knee prosthetic replacement surgery
B. Komatina & M. Paunović
Clinical Hospital Center “Zvezdara”, Belgrade, Serbia
P23
Reducing transfusion rates in fractured neck of femur patients
E. Cairns1, L. R. Kidd2, N. Edgington1 & N. De Zoysa2
1
Blood Conservation Team, North Bristol NHS Trust; 2Department of Anaesthesia, North Bristol NHS Trust, UK
P24
Intraoperative cell salvage as an alternative to allogeneic (donated) blood transfusion: an evaluation of the immune
response profile
M. Roets1,2, D. Sturgess2,4, M. P. Obeysekera3, T. V. Tran3, K. Wyssusek1,2, J. E. J. Punnasseril2, D. Da Silva1,2, A. Van Zundert1,2, J. P. Tung2,3,
R. Flower2,3 & M. M. Dean3,5
1
The Royal Brisbane and Women’s Hospital; 2University of Queensland (QLD); 3Australian Red Cross Lifeblood; 4Princess Alexandra
Hospital; 5University of Sunshine Coast, Brisbane, Queensland, Australia
P25
Combined intraoperative platelet and erythrocyte salvage: first evaluation of a new autotransfusion device
A. Mansour1,2,3, M. Roussel4, C. Bendavid5, C. Lefevre5, B. Decouture6, L. Skreko6, F. Gadra6, P. Forest-Villegas6, V. Picard7, J. Y. Py8,
E. Rivery8, C. Bachelot-Loza2, P. Gaussem2,9 & I. Gouin-Thibault3,4
1
CHU de Rennes, Department of Anesthesiology and Critical Care Medicine, Rennes, France; 2Université de Paris, Innovative
Therapies in Haemostasis, INSERM 1140 Paris, France; 3Université de Rennes, CHU de Rennes, INSERM, CIC 1414, Rennes, France;
4
CHU de Rennes, Department of Biological Hematology, Rennes, France; 5CHU de Rennes, Department of Biochemistry, Rennes,
France; 6i-SEP, Nantes, France; 7APHP, Hôpital Kremlin-Bicêtre, Paris, France; 8EFS Centre-Pays de la Loire, France; 9AP-HP, Hôpital
Européen Georges Pompidou, Department of Biological Hematology, Paris, France
P26
Cell salvage: A decade of haemovigilance reporting in the UK
S. Haynes1, D. Poles2, J. Davies2 & S. Narayan2
1
Wythenshawe Hospital, Manchester, UK; 2Serious Hazards of Transfusion (SHOT), Manchester, UK
P27
Basic measures in hip fractures reduce transfusion
S. Zalba Marcos1, L. Muñoa Oteiza2, G. Napal Ongay2, G. Cerdán Rodríguez2, J. M. Sánchez Iglesias1, J. Martínez de Morentin Garraza2,
J. R. Varela Egocheaga2, I. Plaja Martí2, A. Galbete Jiménez1 & J. A. García Erce3
1
Complejo Hospitalario de Navarra; 2Hospital García Orcoyen; 3Banco de Sangre y Tejidos de Navarra, Spain
23E-POSTERS
P28
Patient-specific blood management strategy reduces requirement for intraoperative allogeneic transfusion in major
liver surgery
M. Stoneham1, C. Larkin2, A. Davies2, K. Maher2 & S. Von Kier2
1
Nuffield Dept. Anaesthetics; 2Haemostasis & Blood Conservation Service, Oxford University NHS Foundation Trust, Oxford, UK
P29
Bloodless gynaecological surgery in University of Calabar Teaching Hospital
N. Usoro, Q. Kalu, M. Inyama, H. Olukoya & E. Ekanem
University of Calabar Teaching Hospital, Calabar, Nigeria
P30
Perioperative management of a patient with Bombay blood phenotype undergoing open hip reduction surgery
A. Gardeta
Anesthesia Department, Hospital Severo Ochoa, Madrid, Spain
P31
Global transfusion impact of patient blood management (PBM) programme in a regional hospital
S. Zalba Marcos1, G. Napal Ongay2, L. Muñoa Oteiza2, M. Osinaga Alcaraz2, G. Cerdán Rodríguez2, J. R. Varela Egocheaga2, I. Plaja Martí2,
M. L. Abinzano2, E. Ongay Burgui2, A. Aranguren Azparren1, A. Galbete Jiménez1 & J. A. García Erce3
1
Complejo Hospitalario de Navarra; 2Hospital García Orcoyen de Estella; 3Banco de Sangre y Tejidos de Navarra, Spain
P32
Implementation of MAPBM (Maturity Assessment in Patient Blood Management) in hip fracture
A. Capdevila-Reniu1, A. Ruiz2, M. Navarro1, P. Camacho3 & M. Basora2
1
Internal Medicine Department; 2Anesthesia department; 3Orthopedic surgery and traumatology department, Hospital Clinic
de Barcelona, Spain
24E-POSTERS
Anaemia Effects and Management
P33
Anaemia in presurgical patients: partial analysis
M. A. Zabalegui Goicoechea1, S. Zalba Marcos1, I. Otamendi Goicoechea1, A. Aranguren Azparren1, A. Galbete Jimenez1 & J. A. García-
Erce2
1
Complejo Hospitalario de Navarra; 2Banco de Sangre y Tejidos de Navarra, Spain
P34
The need to screen for anemia in fit and healthy women
C. Dugan1, C. Scott2, S. Abeysiri2, R. McAleavy2, R. Raobaikady2 & T. Richards1
1
University of Western Australia, Perth, Australia; 2The Iron Clinic, London, UK
P35
Anaemia and iron deficiency is common in pregnant women with mental illness
R. Currie, T. Nguyen, N. Khoo & J. Frayne
Medical School & Division of General Practice, University of Western Australia, Perth, Australia
P36
Relation between pre-operative anaemic status, surgery specialty and RBC transfusion
M. Alho, C. Guedes, G. Orfão & J. Tomaz
Blood and Transfusion Medicine Department, Coimbra Hospital and University Center, Coimbra, Portugal
P37
A descriptive Blood sample Volume Analysis in a Multidisciplinary Pediatric Intensive caRE unit (B-VAMPIRE)
T. François, M. Sauthier, J. Charlier, B. Toledano, J. Dessureault, S. Al Omar, J. Lacroix & G. Du Pont-Thibodeau
CHU Sainte-Justine, Montreal, QC, Canada
P38
A retrospective cohort review of pre-operative anaemia and postoperative outcomes in 1,751 colorectal surgical
patients
M. Adamson1, C. Oliver2 & R. Davies1
1
Consultant Anaesthetist; 2Fellow in Perioperative Medicine, University Hospital of Wales, Cardiff, UK
P39
Iron deficiency reduces mitochondrial respiration and changes mitochondrial morphology in mouse skeletal muscle
tissue
K. Cabolis1, T. Richards2, K. J. Smith1 & M. Sajic1
1
Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, United Kingdom; 2University of Western
Australia, Perth, WA, Australia
P40
Significance of common hemogram on diagnosis of iron deficiency in patients for scheduled arthroplasty
S. Zalba Marcos1, M. Polo Gil2, E. Martin Rodríguez2, I. Plaja Martí2, G. Napal Ongay2, M. Osinaga Alcaraz2, J. R. Varela Egocheaga2,
A. Galbete Jiménez1, G. Cerdán Rodríguez2, J. A. García Erce3
1
Complejo Hospitalario de Navarra; 2Hospital García Orcoyen; 3Banco de Sangre y Tejidos de Navarra, Spain
25E-POSTERS
P41
Diagnosis and management of anaemia in gynaecological cancer - The Royal Marsden MILE Prehabilitation Programme
A. Wills, L. Shovel, E. Black & R. Rao Baikady
The Royal Marsden NHS Foundation Trust, London, UK
P42
Development of a PBM program: experience of the Metropolitan Transfusion Service - Bologna, Emilia Romagna
Region, Italy
V. Randi, G. Miccoli, A. Olmo, A. M. Aurelio Strano, M. Benni & A. Cenacchi
Metropolitan Transfusion Service-Bologna, Emilia Romagna Region-Italy
P43
Patient Blood Management (PBM) in Cancer-related Anaemia (CRA): impact on the Need to Transfuse - a retrospective
randomized observational study
C. Jacinto Correia, A. Oliveira & A. Brites
Serviço de ImunoHemoterapia, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal
P44
Operation of a patient blood management outpatient clinic for patients with elective surgery
A. Argyrou¹, M. Tserga¹, KM Milioni², A. Podaras¹, A. Manta¹ & A. Gafou¹
¹Blood Transfusion Department, “Agioi Anargiroi” General & Oncology Hospital, Athens, Greece; ²Outpatient Clinic, “Agioi Anargiroi”
General & Oncology Hospital, Athens, Greece
P45
Evaluation of clinical outcome in treated and untreated anaemic patients undergoing major surgery at University
Hospital Southampton: an observational study 2016-2018
Y. Johnson, J. Plumb, L. Sheppard, S. Berry, M. Edwards, D. Levett & M. Wakatsuki
University Hospital Southampton NHS Foundation Trust, Southampton, UK
P46
Anaemia and iron deficiency: diagnosis and therapy in patients in elective THA and TKA surgery in a polyclinic with high
surgical flow
T. D’Amato, M. Bovio, V. Simili, F. Martorelli, C. Cianchi, G. Monteleone, F. Tasso, D. Tanzi & M. Scardino
Humanitas Research Hospital, Milan, Italy
P47
The management of anaemia chronic disease in microsurgical procedures for the reconstructive surgery
M. B. Rondinelli1, G. Ruocco2, A. Di Bartolomei1, R. Pagnotta1, F. Massarelli1, S. Scali1, S. Minchella1, L. Cecilia1, M. G. Stragapede1,
L. Pierelli1 & N. Felici2
1
Department of Transfusion Medicine; 2Department of Reconstructive Surgery, San Camillo-Forlanini Hospital-Rome, Italy
P48
Fast track anaemia clinic in emergency department
M. Marmifero1, N. Virto1, F. Giacchero1, C. Rognoni2 & R. Guaschino1
1
Medicina Trasfusionale,Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; 2Centre for Research on Health
and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Milan, Italy
26E-POSTERS
P49
An outcome-focused single-centre retrospective study examining the futility of different anaemia thresholds for men
and women in surgical patients
T. Tomić Mahečić1, I. Tucić1, D. Karmelić1, K. Lojna1, M. Moguš1, A. Jumić1, B. Habijanec2, V. Burilovic3 & S. Mihaljević1,4
1
Department of Anaesthesiology and ICU, University Hospital Centre Zagreb, Zagreb; 2Data Raven j.d.o.o., Zagreb; 3Department of
Transfusion Medicine, University Hospital Centre Split, Split; 4University of Zagreb School of Medicine, Zagreb, Croatia
P50
Impact of the implementation of a Patient Blood Management program in a Portuguese Hospital - case study
M. J. Araújo1,2 & R. Pinto
1
Centro Hospitalar Entre o Douro e Vouga, Santa Maria da Feira, Portugal; 2Escola Nacional de Saúde Pública, Lisboa, Portugal
P51
Intravenous iron before cardiac surgery – a single centre experience
R. J. Jones1, R. Morris-Clarke2, G. Greene3, M. Phillips4 & C. Evans5
1
Perioperative Research Fellow University Hospital of Wales, Cardiff, UK; 2Specialist Registrar Welsh School of Anaesthesia, Cardiff,
UK; 3Statistician Cardiff University, Cardiff, UK; 4Cardiac Nurse Case Manager, University Hospital of Wales, Cardiff, UK; 5Consultant
Cardiothoracic Anaesthetist University Hospital of Wales, Cardiff, UK
P52
Charting the course of ‘Gynaemia’ (Patients with Anaemia undergoing Gynaecological Onco-surgery)
S Abeysiri1, N Bhudia2, S Foong2, C Dormido2, R Agarwala2, E Black2 & R Raobaikady2
1
University College London, London, UK; 2Royal Marsden NHS Trust, London, UK
P53
Evaluation of 431 anaemic patients treated with intravenous iron prior to major surgery at University Hospital
Southampton (UHS) between 2016-2019
M. Wakatsuki, L. Sheppard, Y. Johnson, J. Plumb, M. Edwards, M. Grocott, D. Levett & UHS Perioperative Medicine Team
University Hospital Southampton NHS Foundation Trust, Southampton, UK
P54
Review of intravenous iron service provision of pre-operative anaemia management at Queen’s Hospital Romford, UK
A. Minogue, A. Oguns & A. Brownell
Barking Havering and Redbridge NHS Trust. Queen’s Hospital, Romford, UK
P55
IV Iron: Using Quality Improvement methodology to successfully implement a pre-operative IV iron service
D. Hepple, C. Smith & R. Hackett
The James Cook University Hospital, Middlesbrough, UK
P56
Intravenous iron and colorectal surgery: results from a pre-operative anaemia clinic
C. Currie1 & M. Stephens2
1
Speciality Registrar; 2Consultant Anaesthetist, University Hospital Wishaw, Wishaw, UK
27E-POSTERS
P57
Cohort study: Importance of intravenous iron treatment in perioperative transfusion risk prevention in gyneacological
and oncological surgery
S. García Orallo & J. Rodriguez García
Hospital Sierrallana, Anesthesiology Department, Hospital Son Espases, Preventive Medicine Department, Spain
P58
Cardiopulmonary exercise testing before and after intravenous iron: a prospective clinical study - ‘CAPOEIRA-I STUDY’
CArdio PulmOnary Exercise testing and IntRAvenous Iron
J. O. M. Plum, J. Otto, S. Kumar, M. Wakatsuki, D. Levett, W. Schmidt, H. E. Montgomery & M. P. W. Grocott
Centre for Human Integrative Physiology, Faculty of Medicine University of Southampton, Southampton, UK
P59
Evaluation of serum phosphate levels in surgical patients receiving intravenous ferric carboxymaltose
L. K. Wijaya1, D. Dahly2 & T. Richards1
1
Division of Surgery, Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia; 2HRB
Clinical Research Facility Cork, School of Public Health, University College Cork, Ireland
P60
Perioperative anaemia in women undergoing autologous breast reconstruction with free flaps: has the time come
for post-operative parenteral iron therapy?
M. Gorman, R. Agarwala, R. Rao Baikady & A. Khan
Royal Marsden Hospital, London, UK
P61
The effectiveness of postoperative intravenous iron therapy for anaemic patients; results from one specialist cancer
centre
V. Venkat Raman, R. Agarwala, C. Dormido & R. Rao Baikady
Royal Marsden Hospital, London, UK
P62
Comparison of two intravenous iron regimens in the treatment of postoperative anaemia after colorectal cancer
surgery
M. De la Rosa-Estadella, B. Méndez, F. Martínez, F. Carol, M. Fradera & M. J. Laso
Department of Anaesthesiology, Parc Tauli University Hospital, Barcelona, Spain
P63
Iron in the times of COVID-19
S. Abeysiri1, R. Agarwala2, C. Dormido2, E. Black2 & R. Raobaikady2
1
University College London, London, UK; 2Royal Marsden NHS Trust, London, UK
28E-POSTERS
Haemostasis & Thrombosis
P64
Early plasma transfusion and maternal outcomes in women with postpartum haemorrhage: Does the amount of resus-
citation fluids matter?
C. Caram-Deelder1,2, D. D. Henriquez1,2,3, S. le Cessie2,4, J. Zwart5, J. van Roosmalen6, J. Eikenboom7, C. So-Osman8, L. van de Watering8,
J. Zwaginga1,9, A. Koopman-van Gemert10, K. Bloemenkam3 & J. van der Bom1,2, for the TeMpOH-1 study group
1
Jon J van Rood Center for Clinical Transfusion Research Leiden, Sanquin/LUMC; 2Clinical Epidemiology, Leiden University Medical
Center; 3Department of Obstetrics, Leiden University Medical Center; 4Department of Biomedical Data Sciences, Leiden University
Medical Center; 5Department of Obtetrics & Gynaecology, Deventer Hospital, Deventer; 6Athena Institute, Vrije Universiteit Amster-
dam; 7Department of Internal Medicine, division of Thrombosis and Hemostasis, Leiden University Medical Center; 8Sanquin Blood
Bank; 9Department of Immunohematology and Blood Transfusion, Leiden University Medical Center; 10Department of Anaesthesiol-
ogy, Albert Schweitzer Hospital, Dordrecht, The Netherlands
P65
How to conserve blood and blood products during major obstetric haemorrhage
A. Garland, A. Dobru, C. Pritchett & C. Ralph
Department of Anaesthesia and Perioperative Medicine, Royal Cornwall Hospital, UK
P66
Procoagulant membrane dynamics: A novel approach to identify platelet activation in pre-eclampsia
J. Nicholas*1, A. Lee*2, A. Gregory1, K. Roberts1, A. M. Walker1, G. Dobson1, A. W. Poole3; E. O. Agbani**4,5 & L. Chow**1
*
Joint First Authors; **Joint Senior Authors
1
Department of Anesthesiology, Perioperative and Pain Medicine, Cumming School of Medicine, University of Calgary, Alberta,
Canada; 2Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada; 3School of Physiology,
Pharmacology and Neuroscience, University of Bristol, Medical Sciences Building, Bristol, United Kingdom; 4Department of
Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Alberta, Canada; 5Libin Cardiovascular Institute
of Alberta, Calgary, Alberta, Canada
P67
The influence of gestational diabetes mellitus on coagulation in healthy term pregnancy as assessed by rotational
thromboelastometry
J. Lee1,2, V. A. Eley1,2, K. H. Wyssusek1,2, R. M. N. Kimble2,3, M. Way4, J. Cohen2,5 & A. van Zundert1,2
1
Department of Anaesthesia and Perioperative Medicine, The Royal Brisbane and Women’s Hospital, Brisbane, Australia;
2
The University of Queensland, Brisbane, Australia; 3Department of Obstetrics and Gynaecology, The Royal Brisbane and Women’s
Hospital, Brisbane, Australia; 4QIMR Berghofer Medical Research Institute, Brisbane, Australia; 5Department of Intensive Care
Medicine, The Royal Brisbane and Women’s Hospital, Brisbane, Australia
P68
A local audit on blood loss and management in major gynae-oncology surgery at a District General Hospital
A. Cassels-Barker, O. Dow, K. Blightman, P. Alexopoulou, J. Lawrence & A. Tailor
Royal Surrey County Hospital, Guildford, UK
P69
No (wo)man left behind: the use of standardized haemostasis abnormality assessment questionnaire in preoperative
screening reveals a significant number of patients who would otherwise likely be missed
T. Tomić Mahečić, I. Tucić, D. Karmelić, K. Lojna, M. Moguš, A. Jumić, M. Tripković & N. Kovač
Department of Anestesiology, Reanimatology and Intensive Care Medicine, University Hospital Centre Zagreb, Croatia
P70
The prophylactic use of tranexamic acid in hip and knee joint replacement surgery
G. Mousinho, A. Sequeira, S. Repas & J. Martinez
Serviço de de Imunohemoterapia do Centro Hospitalar e Universitário Cova da Beira- CHUCB, EPE, Covilhã, Portugal
29E-POSTERS
P71
The role of thromboelastography (TEG) analysis for diagnosis and management of hypercoagulability in patients
with COVID-19
J. Hartmann, A. Ergang, D. Mason & J. D. Dias
Haemonetics Corp., Boston, MA, USA
P72
Assessing the risk of DIC development in sepsis and SIRS
J. Margarito1, A. Ahmed2 & R. van den Ham1,2
1
Philips Research, Eindhoven, The Netherlands; 2Hemeo B.V., Amsterdam, The Netherlands
P73
Real-world data on the effect of anticoagulants to prevent or treat DIC
B. Bakker1, A. Ahmed2 & R. van den Ham1,2
1
Philips Research, Eindhoven, The Netherlands; 2Hemeo B.V., Amsterdam, The Netherlands
P74
Perioperative PBM beyond anaemia: dual antiplatelet therapy
T. A. Hoffmann1, E. Roussel1, E. Kirchhoff1 & P. Rellecke2
1
Institute for Transfusion Medicine and Clinical Haemostaseology; 2Department of Cardiovascular Surgery, Düsseldorf University
Hospital, Germany
P75
Anticoagulation and antiplatelet management during the perioperative period: a daily practice cohort prospective
study
O. Duranteau, A. Hamriti, T. Tuna, B. Ickx & L. Van Obbergh
Department of Anesthesiology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
P76
Blood transfusion in NOACs intoxication
R. Pombal, L. Vieira, S. Lopes, H. Gomes & M. Figueiredo
Centre of Thrombosis and Hemostasis and Department of Transfusion Medicine, Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E.,
Portugal
P77
Rapid and accurate detection of direct oral anticoagulants by DOAC Dipstick test: study protocol to identify its relation
to plasma and urine concentrations in neurology and cardiology
S. Margetić1, I. Ćelap1, A. Lovrenčić-Huzjan2, D. Delić Brkljačić3, P. Mioč3, S. Šupraha Goreta4 & J. Harenberg5
1
Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; 2Department of Neurology, Sestre
milosrdnice University Hospital Center, Zagreb, Croatia; 3Department of Cardiovascular Diseases, Sestre milosrdnice University
Hospital Center, Zagreb, Croatia; 4Department of Pharmacy, Sestre milosrdnice University Hospital Center, Zagreb, Croatia;
5
DOASENSE GmbH, Heidelberg University, Heidelberg, Germany
P78
Evaluation of sensitivity and specificity of STic Expert® HIT with the pre-test probability tools for the diagnosis of
heparin-induced thrombocytopenia type 2
M. Alves1, T. Gago2 & R. Lopes1
1
Hospital De Santa Cruz (CHLO); 2Hospital De São Francisco Xavier (CHLO), Lisbon, Portugal
30You can also read
